Global Ready to use Therapeutic Food Market Size By Type (Solid, Semi-Solid Paste), By Application (Food Industry, Medical Industry), By Region, And Segment Forecasts, 2023 to 2032

The Global Ready to Use Therapeutic Food (RUTF) Market was valued at USD 1.45 billion in 2023 and is expected to reach USD 3.22 billion by 2031, growing at a CAGR of 10.3% during the forecast period from 2023 to 2031. The market's growth is primarily fueled by the rising prevalence of child malnutrition globally, increased humanitarian initiatives, and government support for community-based nutrition programs. RUTF products—nutrient-dense, energy-rich food pastes—are widely recognized for their role in treating severe acute malnutrition (SAM) without the need for hospitalization. Their portability, long shelf-life, and effectiveness make them a critical solution in emergency nutrition interventions and therapeutic feeding programs.

Drivers:

Rising Global Burden of Malnutrition:

A growing number of children, especially in low-income and conflict-affected countries, suffer from SAM, driving demand for cost-effective, ready-to-administer solutions like RUTF.

Humanitarian and Governmental Support:

International bodies like UNICEF and WHO have endorsed the widespread use of RUTF, while NGOs and public health institutions continue to increase distribution and funding.

Improved Access and Supply Chain Innovations:

Advancements in logistics, localized production units, and public-private partnerships have improved the availability and affordability of RUTF across emerging markets.

Restraints:

High Production Costs:

Peanut-based RUTF, the most widely used formulation, often faces price volatility due to raw material costs, affecting affordability in low-resource settings.

Regulatory and Ethical Challenges:

Concerns about over-reliance on imported RUTF, the need for culturally acceptable alternatives, and ensuring quality standards across suppliers can limit widespread adoption.

Opportunity:

Plant-Based and Localized Formulations:

Innovations in plant-based RUTF and country-specific ingredient alternatives (e.g., chickpea, soy, maize) offer new avenues for affordable and culturally appropriate solutions.

Public-Private Collaborations:

Emerging partnerships between health agencies, governments, and RUTF manufacturers are fostering regional production, supporting both nutritional goals and local economies.

Market by System Type Insights:

The Peanut-Based RUTF segment dominated the market in 2023 due to its proven clinical efficacy and wide acceptance in treatment protocols. However, the Plant-Based RUTF segment is anticipated to exhibit the fastest growth, driven by innovation in allergen-free, sustainable alternatives and increased demand in regions with peanut allergies or limited peanut cultivation.

Market by End-use Insights:

NGOs and Humanitarian Agencies emerged as the primary end-users in 2023, accounting for more than 55% of the total demand. These organizations lead large-scale distribution during crises and long-term nutrition campaigns. Meanwhile, Government Health Programs are expanding their role, integrating RUTF into national strategies for child nutrition, especially in Sub-Saharan Africa and South Asia.

Market by Regional Insights:

Africa held the largest market share in 2023, driven by the continent’s high burden of child malnutrition and strong support from international aid programs. Asia-Pacific is expected to register the highest growth rate, particularly in countries like India, Bangladesh, and Pakistan, where RUTF adoption is gaining momentum through government-supported initiatives and localized manufacturing.

Competitive Scenario:

Key players in the global RUTF market include Nutriset, Mana Nutrition, Edesia Nutrition, Hilina Enriched Foods, InnoFaso, and Compact India Pvt Ltd. These companies focus on localized production, regulatory compliance, and product diversification to maintain market leadership.

Recent Developments:

2023: Edesia Nutrition launched a new plant-based RUTF formula targeting peanut-allergic populations in West Africa.

2024: UNICEF signed long-term agreements with local manufacturers across Africa and Asia to scale up decentralized RUTF production.

2025: Mana Nutrition collaborated with local agricultural cooperatives in Malawi to strengthen the supply chain for therapeutic food ingredients.

Scope of Work – Global Ready to Use Therapeutic Food Market

Key Market Developments:

Nutriset expanded its franchise network to enable more RUTF production in East Africa (2023).

Hilina Enriched Foods announced a capacity expansion to support Ethiopia’s growing therapeutic nutrition demand (2024).

Compact India Pvt Ltd. introduced a new RUTF formulation customized for Indian government health schemes (2025).

FAQs:

1) What is the current market size of the Global Ready to Use Therapeutic Food Market?

The market was valued at USD 1.45 billion in 2023.

2) What is the major growth driver of the Global Ready to Use Therapeutic Food Market?

The primary driver is the rising global burden of severe acute malnutrition among children.

3) Which is the largest region during the forecast period in the Global Ready to Use Therapeutic Food Market?

Africa is the largest region due to the high prevalence of malnutrition and strong aid support.

4) Which segment accounted for the largest market share in Global Ready to Use Therapeutic Food Market?

The Peanut-Based RUTF segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Ready to Use Therapeutic Food Market?

Key players include Nutriset, Mana Nutrition, Edesia Nutrition, Hilina Enriched Foods, and InnoFaso.

Let me know if you'd like this in a Word or PDF document as well.